Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors

Conditions:   Obesity;   Weight Loss Interventions:   Drug: Empagliflozin Arm;   Other: Control Arm;   Other: Exercise capacity VO2 maximum determination;   Other: Exercise Challenge Sponsor:   University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials